Header Logo

Philip Cinnamon Comp

TitleProf Emeritus,Clinical
InstitutionUniversity of Oklahoma Health Sciences Center
DepartmentMedicine Hematology/Oncology
AddressNT 5850
940 NE 13th St
Oklahoma City OK 73104
Phone405/271-6466
Fax0
vCardDownload vCard

    Collapse Research 
    Collapse research activities and funding
    R01HL030443     (COMP, PHILIP C)Jun 1, 1983 - Mar 31, 1997
    NIH
    PROTEIN S AND MYOCARDIAL INFARCTION
    Role: Principal Investigator

    R55HL030443     (COMP, PHILIP C)Sep 30, 1991 - Mar 31, 1992
    NIH
    PROTEIN S AND MYOCARDIAL INFARCTION
    Role: Principal Investigator

    IS1BX003088     (COMP, PHILIP CINNAMON)Jan 1, 2015 - Sep 30, 2015
    NIH
    Environmental Housing with Automatic Watering System
    Role: Principal Investigator

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Iqbal M, Comp PC, Wu DH. Progression of an untreated pseudotumor. Haemophilia. 2017 09; 23(5):e464-e466. PMID: 28664672.
      Citations:    Fields:    Translation:Humans
    2. Tafur AJ, Dale G, Cherry M, Wren JD, Mansfield AS, Comp P, Rathbun S, Stoner JA. Prospective evaluation of protein C and factor VIII in prediction of cancer-associated thrombosis. Thromb Res. 2015 Dec; 136(6):1120-5. PMID: 26475410.
      Citations:    Fields:    Translation:Humans
    3. Douketis JD, Ginsberg JS, Haley S, Julian J, Dwyer M, Levine M, Eisenberg PR, Smart R, Tsui W, White RH, Morris TA, Kaatz S, Comp PC, Crowther MA, Kearon C, Kassis J, Bates SM, Schulman S, Desjardins L, Taillefer R, Begelman SM, Gerometta M. Accuracy and safety of (99m)Tc-labeled anti-D-dimer (DI-80B3) Fab' fragments (ThromboView®) in the diagnosis of deep vein thrombosis: a phase II study. Thromb Res. 2012 Sep; 130(3):381-9. PMID: 22658414.
      Citations: 8     Fields:    Translation:HumansCTClinical Trials
    4. Madhoun MF, Maple JT, Comp PC. Phosphofructokinase deficiency and portal and mesenteric vein thrombosis. Am J Med Sci. 2011 May; 341(5):417-9. PMID: 21358310.
      Citations:    Fields:    Translation:Humans
    5. Ginsberg JS, Davidson BL, Comp PC, Francis CW, Friedman RJ, Huo MH, Lieberman JR, Muntz JE, Raskob GE, Clements ML, Hantel S, Schnee JM, Caprini JA. Oral thrombin inhibitor dabigatran etexilate vs North American enoxaparin regimen for prevention of venous thromboembolism after knee arthroplasty surgery. J Arthroplasty. 2009 Jan; 24(1):1-9. PMID: 18534438.
      Citations: 132     Fields:    Translation:Humans
    6. Turpie AG, Bauer KA, Caprini JA, Comp PC, Gent M, Muntz JE. Fondaparinux combined with intermittent pneumatic compression vs. intermittent pneumatic compression alone for prevention of venous thromboembolism after abdominal surgery: a randomized, double-blind comparison. J Thromb Haemost. 2007 Sep; 5(9):1854-61. PMID: 17723125.
      Citations: 25     Fields:    Translation:Humans
    7. Acree LS, Comp PC, Whitsett TL, Montgomery PS, Nickel KJ, Fjeldstad AS, Fjeldstad C, Gardner AW. The influence of obesity on calf blood flow and vascular reactivity in older adults. Dyn Med. 2007 Mar 26; 6:4. PMID: 17386093.
      Citations:    
    8. Fjeldstad AS, Fjeldstad C, Acree LS, Nickel KJ, Montgomery PS, Comp PC, Whitsett TL, Gardner AW. The relationship between arterial elasticity and metabolic syndrome features. Angiology. 2007 Feb-Mar; 58(1):5-10. PMID: 17351152.
      Citations: 9     Fields:    Translation:Humans
    9. Dunn ST, Allen RA, Bates F, McNamara V, Comp P. Abnormal melt curve profile during prothrombin 20210G --> A analysis due to the 20209C --> T variant. Blood Coagul Fibrinolysis. 2006 Oct; 17(7):599-602. PMID: 16988559.
      Citations: 4     Fields:    Translation:HumansCells
    10. Smith SA, Comp PC, Morrissey JH. Traces of factor VIIa modulate thromboplastin sensitivity to factors V, VII, X, and prothrombin. J Thromb Haemost. 2006 Jul; 4(7):1553-8. PMID: 16839353.
      Citations: 1     Fields:    Translation:Humans
    11. Comp PC. Should coagulation tests be used to determine which oral contraceptive users have an increased risk of thrombophlebitis? Contraception. 2006 Jan; 73(1):4-5. PMID: 16371288.
      Citations:    Fields:    Translation:Humans
    12. Colwell CW, Berkowitz SD, Lieberman JR, Comp PC, Ginsberg JS, Paiement G, McElhattan J, Roth AW, Francis CW. Oral direct thrombin inhibitor ximelagatran compared with warfarin for the prevention of venous thromboembolism after total knee arthroplasty. J Bone Joint Surg Am. 2005 Oct; 87(10):2169-77. PMID: 16203879.
      Citations: 11     Fields:    Translation:HumansCTClinical Trials
    13. Kearon C, Comp P, Douketis J, Royds R, Yamada K, Gent M. Dose-response study of recombinant human soluble thrombomodulin (ART-123) in the prevention of venous thromboembolism after total hip replacement. J Thromb Haemost. 2005 May; 3(5):962-8. PMID: 15869592.
      Citations: 17     Fields:    Translation:Humans
    14. Igarashi H, Medina KL, Yokota T, Rossi MI, Sakaguchi N, Comp PC, Kincade PW. Early lymphoid progenitors in mouse and man are highly sensitive to glucocorticoids. Int Immunol. 2005 May; 17(5):501-11. PMID: 15746243.
      Citations: 25     Fields:    Translation:HumansAnimalsCells
    15. Kinasewitz GT, Yan SB, Basson B, Comp P, Russell JA, Cariou A, Um SL, Utterback B, Laterre PF, Dhainaut JF. Universal changes in biomarkers of coagulation and inflammation occur in patients with severe sepsis, regardless of causative micro-organism [ISRCTN74215569]. Crit Care. 2004 Apr; 8(2):R82-90. PMID: 15025782.
      Citations: 85     Fields:    Translation:HumansCTClinical Trials
    16. Hensley K, Benaksas EJ, Bolli R, Comp P, Grammas P, Hamdheydari L, Mou S, Pye QN, Stoddard MF, Wallis G, Williamson KS, West M, Wechter WJ, Floyd RA. New perspectives on vitamin E: gamma-tocopherol and carboxyelthylhydroxychroman metabolites in biology and medicine. Free Radic Biol Med. 2004 Jan 01; 36(1):1-15. PMID: 14732286.
      Citations: 71     Fields:    Translation:HumansAnimals
    17. Francis CW, Berkowitz SD, Comp PC, Lieberman JR, Ginsberg JS, Paiement G, Peters GR, Roth AW, McElhattan J, Colwell CW. Comparison of ximelagatran with warfarin for the prevention of venous thromboembolism after total knee replacement. N Engl J Med. 2003 Oct 30; 349(18):1703-12. PMID: 14585938.
      Citations: 41     Fields:    Translation:HumansCTClinical Trials
    18. Comp PC. Selective factor Xa inhibition improves efficacy of venous thromboembolism prophylaxis in orthopedic surgery. Pharmacotherapy. 2003 Jun; 23(6):772-87. PMID: 12820819.
      Citations:    Fields:    Translation:Humans
    19. Stearns-Kurosawa DJ, Burgin C, Parker D, Comp P, Kurosawa S. Bimodal distribution of soluble endothelial protein C receptor levels in healthy populations. J Thromb Haemost. 2003 Apr; 1(4):855-6. PMID: 12871429.
      Citations: 5     Fields:    Translation:Humans
    20. Comp PC. Treatment and management of acute venous thromboembolic disease. Thromb Res. 2003; 111(1-2):3-8. PMID: 14644071.
      Citations:    Fields:    Translation:Humans
    21. Kottke-Marchant K, Comp P. Laboratory issues in diagnosing abnormalities of protein C, thrombomodulin, and endothelial cell protein C receptor. Arch Pathol Lab Med. 2002 Nov; 126(11):1337-48. PMID: 12421141.
      Citations: 10     Fields:    Translation:Humans
    22. Comp PC, Miller JD, Mayo KW, Wagner S, Russell MW. Outcomes of dalteparin use following total knee arthroplasty: a retrospective analysis. Expert Rev Pharmacoecon Outcomes Res. 2002 Oct; 2(5):427-34. PMID: 19807466.
      Citations:    Fields:    
    23. Rossi MI, Yokota T, Medina KL, Garrett KP, Comp PC, Schipul AH, Kincade PW. B lymphopoiesis is active throughout human life, but there are developmental age-related changes. Blood. 2003 Jan 15; 101(2):576-84. PMID: 12393702.
      Citations: 35     Fields:    Translation:HumansAnimalsCells
    24. Strandness DE, Dalman RL, Panian S, Rendell MS, Comp PC, Zhang P, Forbes WP. Effect of cilostazol in patients with intermittent claudication: a randomized, double-blind, placebo-controlled study. Vasc Endovascular Surg. 2002 Mar-Apr; 36(2):83-91. PMID: 11951094.
      Citations: 15     Fields:    Translation:HumansCTClinical Trials
    25. Igarashi H, Kouro T, Yokota T, Comp PC, Kincade PW. Age and stage dependency of estrogen receptor expression by lymphocyte precursors. Proc Natl Acad Sci U S A. 2001 Dec 18; 98(26):15131-6. PMID: 11752459.
      Citations: 32     Fields:    Translation:HumansAnimalsCells
    26. Rossi MI, Medina KL, Garrett K, Kolar G, Comp PC, Shultz LD, Capra JD, Wilson P, Schipul A, Kincade PW. Relatively normal human lymphopoiesis but rapid turnover of newly formed B cells in transplanted nonobese diabetic/SCID mice. J Immunol. 2001 Sep 15; 167(6):3033-42. PMID: 11544286.
      Citations: 7     Fields:    Translation:HumansAnimalsCells
    27. Lee A, Agnelli G, Büller H, Ginsberg J, Heit J, Rote W, Vlasuk G, Costantini L, Julian J, Comp P, van Der Meer J, Piovella F, Raskob G, Gent M. Dose-response study of recombinant factor VIIa/tissue factor inhibitor recombinant nematode anticoagulant protein c2 in prevention of postoperative venous thromboembolism in patients undergoing total knee replacement. Circulation. 2001 Jul 03; 104(1):74-8. PMID: 11435341.
      Citations: 22     Fields:    Translation:HumansCTClinical Trials
    28. Comp PC, Spiro TE, Friedman RJ, Whitsett TL, Johnson GJ, Gardiner GA, Landon GC, Jové M. Prolonged enoxaparin therapy to prevent venous thromboembolism after primary hip or knee replacement. Enoxaparin Clinical Trial Group. J Bone Joint Surg Am. 2001 Mar; 83(3):336-45. PMID: 11263636.
      Citations: 23     Fields:    Translation:HumansCTClinical Trials
    29. Rudnicka AR, Miller GJ, Nelson T, Doray D, Comp PC. An association between plasma free protein s concentration and risk of coronary heart disease in middle-aged men. Thromb Res. 2001 Jan 15; 101(2):1-11. PMID: 11342201.
      Citations: 5     Fields:    Translation:Humans
    30. Birdwell BG, Raskob GE, Whitsett TL, Durica SS, Comp PC, George JN, Tytle TL, Owen WL, McKee PA. Predictive value of compression ultrasonography for deep vein thrombosis in symptomatic outpatients: clinical implications of the site of vein noncompressibility. Arch Intern Med. 2000 Feb 14; 160(3):309-13. PMID: 10668832.
      Citations: 5     Fields:    Translation:Humans
    31. Carson CW, Comp PC, Rezaie AR, Esmon NL, Esmon CT. Antibodies to thrombomodulin are found in patients with lupus anticoagulant and unexplained thrombosis. J Rheumatol. 2000 Feb; 27(2):384-90. PMID: 10685802.
      Citations: 3     Fields:    Translation:Humans
    32. Sindhav JB, Comp PC, Chandrasekaran K. Hyperhomocysteinemia, aortic thrombus, and peripheral arterial emboli--a case report. Angiology. 1999 Jul; 50(7):599-603. PMID: 10432000.
      Citations:    Fields:    Translation:Humans
    33. Comp PC. Advances in the etiology and treatment of venous thromboembolism. Adv Intern Med. 1999; 44:59-89. PMID: 9929705.
      Citations:    Fields:    Translation:Humans
    34. Comp PC, Voegeli T, McCutchen JW, Skoutakis VA, Trowbridge A, Overdyke WL. A comparison of danaparoid and warfarin for prophylaxis against deep vein thrombosis after total hip replacement: The Danaparoid Hip Arthroplasty Investigators Group. Orthopedics. 1998 Oct; 21(10):1123-8. PMID: 9801236.
      Citations: 2     Fields:    Translation:HumansCTClinical Trials
    35. Birdwell BG, Raskob GE, Whitsett TL, Durica SS, Comp PC, George JN, Tytle TL, McKee PA. The clinical validity of normal compression ultrasonography in outpatients suspected of having deep venous thrombosis. Ann Intern Med. 1998 Jan 01; 128(1):1-7. PMID: 9424975.
      Citations: 31     Fields:    Translation:Humans
    36. Eichner JE, Moore WE, Schechter E, Reynolds DW, Morrissey JH, Comp PC. Activated factor VII levels in patients with angiographically confirmed coronary artery disease. Am J Cardiol. 1997 Jul 15; 80(2):217-9. PMID: 9230166.
      Citations:    Fields:    Translation:Humans
    37. Comp PC. Thrombophilic mechanisms of OCs. Int J Fertil Womens Med. 1997; Suppl 1:170-6. PMID: 9168376.
      Citations:    Fields:    Translation:HumansCells
    38. Raskob GE, Durica SS, Owen WL, Comp PC. Monitoring low-dose warfarin therapy by a central laboratory and implications for clinical trials and patient care. The Coumadin Aspirin Reinfarction (CARS) Pilot Study Group. Am J Cardiol. 1996 Nov 01; 78(9):1074-6. PMID: 8916497.
      Citations:    Fields:    Translation:Humans
    39. Eichner JE, Moore WE, McKee PA, Schechter E, Reynolds DW, Qi H, Comp PC. Fibrinogen levels in women having coronary angiography. Am J Cardiol. 1996 Jul 01; 78(1):15-8. PMID: 8712111.
      Citations: 1     Fields:    Translation:Humans
    40. Burstein SA, Peng J, Friese P, Wolf RF, Harrison P, Downs T, Hamilton K, Comp P, Dale GL. Cytokine-induced alteration of platelet and hemostatic function. Stem Cells. 1996; 14 Suppl 1:154-62. PMID: 11012216.
      Citations: 15     Fields:    Translation:HumansAnimalsCells
    41. Raskob GE, Durica SS, Morrissey JH, Owen WL, Comp PC. Effect of treatment with low-dose warfarin-aspirin on activated factor VII. Blood. 1995 Jun 01; 85(11):3034-9. PMID: 7756639.
      Citations: 3     Fields:    Translation:HumansCTClinical Trials
    42. Lane DM, McConathy WJ, Laughlin LO, Comp PC, von Albertini B, Bricker LA, Kozlovskis P, Lees RS, Dorrier C. Selective removal of plasma low density lipoprotein with the HELP system: biweekly versus weekly therapy. Atherosclerosis. 1995 Apr 24; 114(2):203-11. PMID: 7605389.
      Citations: 3     Fields:    Translation:HumansCTClinical Trials
    43. Smirnov MD, Triplett DT, Comp PC, Esmon NL, Esmon CT. On the role of phosphatidylethanolamine in the inhibition of activated protein C activity by antiphospholipid antibodies. J Clin Invest. 1995 Jan; 95(1):309-16. PMID: 7814631.
      Citations: 19     Fields:    Translation:Humans
    44. Goodman SG, Langer A, Durica SS, Raskob GE, Comp PC, Gray RJ, Hall JH, Kelley RP, Hua TA, Lee RJ, et al. Safety and anticoagulation effect of a low-dose combination of warfarin and aspirin in clinically stable coronary artery disease. Coumadin Aspirin Reinfarction (CARS) Pilot Study Group. Am J Cardiol. 1994 Oct 01; 74(7):657-61. PMID: 7942522.
      Citations: 3     Fields:    Translation:HumansCTClinical Trials
    45. Raskob GE, Comp PC. Preventing systemic embolism in patients with abnormal ventricular function. Cardiol Clin. 1994 Aug; 12(3):477-85. PMID: 7805080.
      Citations:    Fields:    Translation:Humans
    46. Comp PC, Zacur HA. Contraceptive choices in women with coagulation disorders. Am J Obstet Gynecol. 1993 Jun; 168(6 Pt 2):1990-3. PMID: 8512043.
      Citations: 1     Fields:    Translation:Humans
    47. Lane DM, McConathy WJ, Laughlin LO, Comp PC, von Albertini B, Gibson SM, Bricker LA, Kozlovskis P, Dorrier C. Weekly treatment of diet/drug-resistant hypercholesterolemia with the heparin-induced extracorporeal low-density lipoprotein precipitation (HELP) system by selective plasma low-density lipoprotein removal. Am J Cardiol. 1993 Apr 01; 71(10):816-22. PMID: 8456760.
      Citations: 1     Fields:    Translation:HumansCellsCTClinical Trials
    48. Morrissey JH, Macik BG, Neuenschwander PF, Comp PC. Quantitation of activated factor VII levels in plasma using a tissue factor mutant selectively deficient in promoting factor VII activation. Blood. 1993 Feb 01; 81(3):734-44. PMID: 8427965.
      Citations: 68     Fields:    Translation:Humans
    49. Comp PC. Coumarin-induced skin necrosis. Incidence, mechanisms, management and avoidance. Drug Saf. 1993 Feb; 8(2):128-35. PMID: 8452655.
      Citations: 4     Fields:    Translation:Humans
    50. Alving BM, Comp PC. Recent advances in understanding clotting and evaluating patients with recurrent thrombosis. Am J Obstet Gynecol. 1992 Oct; 167(4 Pt 2):1184-91. PMID: 1415444.
      Citations: 1     Fields:    Translation:Humans
    51. Squires RA, Smith S, Pennington LR, Comp PC. Blockade of protein C activation reduces microvascular surgical blood loss. J Surg Res. 1992 Jun; 52(6):560-4. PMID: 1528031.
      Citations:    Fields:    Translation:Animals
    52. Lane DM, McConathy WJ, Comp PC, Gilcher RO. Afibrinogenemia and hypobetalipoproteinemia in a kindred. Arch Intern Med. 1991 Apr; 151(4):800-4. PMID: 2012467.
      Citations:    Fields:    Translation:Humans
    53. Garcia-Maldonado M, Kaufman CE, Comp PC. Decrease in endothelial cell-dependent protein C activation induced by thrombomodulin by treatment with cyclosporine. Transplantation. 1991 Mar; 51(3):701-5. PMID: 1848730.
      Citations: 4     Fields:    Translation:AnimalsCells
    54. Schmidel DK, Nelson RM, Broxson EH, Comp PC, Marlar RA, Long GL. A 5.3-kb deletion including exon XIII of the protein S alpha gene occurs in two protein S-deficient families. Blood. 1991 Feb 01; 77(3):551-9. PMID: 1671337.
      Citations: 6     Fields:    Translation:HumansCells
    55. Comp PC, Forristall J, West CD, Trapp RG. Free protein S levels are elevated in familial C4b-binding protein deficiency. Blood. 1990 Dec 15; 76(12):2527-9. PMID: 2148274.
      Citations: 4     Fields:    Translation:Humans
    56. Comp PC, Elrod JP, Karzenski S. Warfarin-induced skin necrosis. Semin Thromb Hemost. 1990 Oct; 16(4):293-8. PMID: 2281319.
      Citations: 6     Fields:    Translation:Humans
    57. Shah VO, Zamora PO, Mills SL, Mann PL, Comp PC. In vitro studies with the platelet-reactive antibody 50H.19 and its fragments. Thromb Res. 1990 Jun 01; 58(5):493-504. PMID: 2368034.
      Citations:    Fields:    Translation:HumansCells
    58. D'Angelo A, Vigano-D'Angelo S, Esmon CT, Comp PC. Acquired deficiencies of protein S. Protein S activity during oral anticoagulation, in liver disease, and in disseminated intravascular coagulation. J Clin Invest. 1988 May; 81(5):1445-54. PMID: 3284913.
      Citations: 25     Fields:    Translation:Humans
    59. Coller BS, Owen J, Jesty J, Horowitz D, Reitman MJ, Spear J, Yeh T, Comp PC. Deficiency of plasma protein S, protein C, or antithrombin III and arterial thrombosis. Arteriosclerosis. 1987 Sep-Oct; 7(5):456-62. PMID: 2960305.
      Citations: 9     Fields:    Translation:Humans
    60. Boerger LM, Morris PC, Thurnau GR, Esmon CT, Comp PC. Oral contraceptives and gender affect protein S status. Blood. 1987 Feb; 69(2):692-4. PMID: 2948582.
      Citations: 15     Fields:    Translation:Humans
    61. Esmon NL, D'Angelo A, Vigano-D'Angelo S, Esmon CT, Comp PC. Analysis of protein C and protein S in disease states. Dev Biol Stand. 1987; 67:75-82. PMID: 2956141.
      Citations:    Fields:    Translation:Humans
    62. Esmon CT, Vigano-D'Angelo S, D'Angelo A, Comp PC. Anticoagulation proteins C and S. Adv Exp Med Biol. 1987; 214:47-54. PMID: 2959034.
      Citations: 6     Fields:    Translation:Humans
    63. Comp PC. Clinical implications of the protein C/protein S system. Ann N Y Acad Sci. 1987; 509:149-55. PMID: 2962528.
      Citations: 3     Fields:    Translation:HumansAnimals
    64. Comp PC, Thurnau GR, Welsh J, Esmon CT. Functional and immunologic protein S levels are decreased during pregnancy. Blood. 1986 Oct; 68(4):881-5. PMID: 2944555.
      Citations: 29     Fields:    Translation:Humans
    65. Clouse LH, Comp PC. The regulation of hemostasis: the protein C system. N Engl J Med. 1986 May 15; 314(20):1298-304. PMID: 3010107.
      Citations: 50     Fields:    Translation:Humans
    66. Vigano D'Angelo S, Comp PC, Esmon CT, D'Angelo A. Relationship between protein C antigen and anticoagulant activity during oral anticoagulation and in selected disease states. J Clin Invest. 1986 Feb; 77(2):416-25. PMID: 3511097.
      Citations: 12     Fields:    Translation:Humans
    67. Comp PC, Doray D, Patton D, Esmon CT. An abnormal plasma distribution of protein S occurs in functional protein S deficiency. Blood. 1986 Feb; 67(2):504-8. PMID: 2935211.
      Citations: 25     Fields:    Translation:HumansCells
    68. Comp PC. Hereditary disorders predisposing to thrombosis. Prog Hemost Thromb. 1986; 8:71-102. PMID: 3031738.
      Citations: 3     Fields:    Translation:HumansCells
    69. Comp PC, Esmon CT. Recurrent venous thromboembolism in patients with a partial deficiency of protein S. N Engl J Med. 1984 Dec 13; 311(24):1525-8. PMID: 6239102.
      Citations: 54     Fields:    Translation:Humans
    70. Comp PC, Nixon RR, Cooper MR, Esmon CT. Familial protein S deficiency is associated with recurrent thrombosis. J Clin Invest. 1984 Dec; 74(6):2082-8. PMID: 6239877.
      Citations: 63     Fields:    Translation:Humans
    71. Esmon CT, DeBault L, Carroll RC, Comp PC, Esmon NL. Biochemical and physiological aspects of protein c. Ric Clin Lab. 1984 Jul-Sep; 14(3):455-68. PMID: 6098000.
      Citations:    Fields:    Translation:HumansAnimalsCells
    72. Comp PC. Animal studies of protein C physiology. Semin Thromb Hemost. 1984 Apr; 10(2):149-53. PMID: 6330902.
      Citations: 2     Fields:    Translation:AnimalsCells
    73. Comp PC, Nixon RR, Esmon CT. Determination of functional levels of protein C, an antithrombotic protein, using thrombin-thrombomodulin complex. Blood. 1984 Jan; 63(1):15-21. PMID: 6317087.
      Citations: 12     Fields:    Translation:HumansAnimals
    74. Comp PC. Heparin-protein C interaction. Nouv Rev Fr Hematol. 1984; 26(4):239-42. PMID: 6089102.
      Citations: 1     Fields:    Translation:Humans
    75. Comp PC. The activation and effects of protein C, an antithrombotic protein, in vivo. Surv Synth Pathol Res. 1984; 3(1):31-7. PMID: 6095400.
      Citations:    Fields:    Translation:HumansAnimals
    76. Comp PC, Jacocks RM, Ferrell GL, Esmon CT. Activation of protein C in vivo. J Clin Invest. 1982 Jul; 70(1):127-34. PMID: 6177716.
      Citations: 16     Fields:    Translation:Animals
    77. Comp PC, Esmon CT. Generation of fibrinolytic activity by infusion of activated protein C into dogs. J Clin Invest. 1981 Nov; 68(5):1221-8. PMID: 6895378.
      Citations: 31     Fields:    Translation:AnimalsCells
    78. Comp PC, Esmon CT. Activated protein C inhibits platelet prothrombin-converting activity. Blood. 1979 Dec; 54(6):1272-81. PMID: 508937.
      Citations: 18     Fields:    Translation:AnimalsCells
    79. Steves CR, Kopta JA, Taylor FB, Jacocks R, Comp PC. Coagulolysis assay in the detection of deep vein thrombosis in the orthopedic patient. A preliminary report. Clin Orthop Relat Res. 1979 Jul-Aug; (142):190-5. PMID: 498636.
      Citations:    Fields:    Translation:Humans
    80. Comp PC. A rapid purification of streptokinase by affinity chromatography. Thromb Res. 1979 Feb-Mar; 14(2-3):405-11. PMID: 155895.
      Citations:    Fields:    Translation:HumansCells
    81. Comp PC, Jacocks RM, Taylor FB. The dilute whole blood clot lysis assay: a screening method for identifying postoperative patients with a high incidence of deep venous thrombosis. J Lab Clin Med. 1979 Jan; 93(1):120-7. PMID: 759520.
      Citations: 3     Fields:    Translation:Humans
    Comp's Networks
    Click the
    Explore
    buttons for more information and interactive visualizations!
    Concepts (393)
    Explore
    _
    Co-Authors (7)
    Explore
    _
    Similar People (60)
    Explore
    _
    Same Department Expand Description
    Explore
    _
    Physical Neighbors
    _